Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06402669 · ClinicalTrials.gov registry record
Extremity Trauma At a Level 1 Trauma Center
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 20,000
- Enrollment target
NCT06402669: Completed study, sponsored by Arrowhead Regional Medical Center.
NCT06402669 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 20,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06402669 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 20,000 participants
- Enrollment target
Study Summary
Blunt vascular trauma to the lower extremity has been associated with injuries to the anteroposterior tibial arteries or popliteal artery in the form of transection, occlusion, or intimal injury. With many blunt injuries resulting in orthopedic fractures, the incidence of limb loss increases substantial. Distal vascular injuries combined with complex orthopedic fractures are more likely to result in limb loss. A recent retrospective study showed two main predicative factors resulting in limb loss was a result of multi-segmental bone fractures and prolong ischemic time greater then 10 hours.
Primary Outcome
Incidence of mortality associated with transfer status
Interventions
- OTHER Packed Red Blood Cell Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2022-01-01 |
| Est. Completion | 2024-01-01 |
What the finished NCT06402669 record still lists
NCT06402669 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Packed Red Blood Cell Administration is the first listed.
NCT06402669 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06402669 about?
NCT06402669 is a clinical study titled "Extremity Trauma At a Level 1 Trauma Center". Blunt vascular trauma to the lower extremity has been associated with injuries to the anteroposterior tibial arteries or popliteal artery in the form of transection, occlusion, or intimal injury. With many blunt injuries resulting in orthopedic fractures, the incidence of limb loss increases substan...
What is the current status of trial NCT06402669?
This trial is currently completed. The enrollment target is 20,000 participants. The study started on 2022-01-01. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT06402669?
The interventions under investigation include: Packed Red Blood Cell Administration (OTHER).
Who is sponsoring clinical trial NCT06402669?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI